Daiichi Sankyo Introduction Seminar

  • Tuesday, 21/09/2021
  • 10:00 - 11:00

Online Event

Event Description {{detailsExpanded ? '- Show Less' : '+ Show More'}}

Daiichi Sankyo logo3.png

Opportunities to collaborate with global pharmaceutical company, Daiichi Sankyo

Join Dr Kunihiko Fujii, introduced by Professor Neil Carragher, to find out more about collaborating with Daiichi Sankyo, the global pharmaceutical company originating from Japan.

This webinar is a great opportunity to learn more about the company itself, their research priorities and collaboration structures available to support your translational research, as well as potentially arranging a follow up 1:1 call, allowing you to further explore partnering options.

Dr Fujii will give an overview of Daiichi Sankyo and their core areas of interest which include:

  • Validated binder against novel antigen that highly expresses in tumor cell with no expression in normal cell
  • Novel technology of AAV gene therapies which enable as follows:
    • Repeated dosing by avoiding effect of neutralization antibody to AAV
    • Larger gene size delivery with AAV vector (more than 5 kilobases)
  • Novel DDS technology of siRNA or antisense oligonucleotides (ASO) for tissue specific targeting to CNS (in addition muscle and cancer tissue)

There will be an opportunity to ask questions after the presentation.



Dr Kunihiko Fujii has been Manager of Business Development & Licensing Search & Evaluation programme at Daiichi Sankyo since 2019. He has worked at the company since gaining his PhD from the University of Tokyo.


-Supported by Interface_logo_300dpi_cymk-rs4.jpg


Registration is now closed.

For assistance, please contact us on eievents@ei.ed.ac.uk

Enter your details to register for this event. You can also log in or confirm your email address to view and register for other events.


Please complete any required questions

View Other Events

Edinburgh Innovations Limited is the University of Edinburgh’s commercialisation service. Edinburgh Innovations is a wholly owned subsidiary company of the University of Edinburgh. Your data will be held securely and will not be passed on to any third parties. Consent can be withdrawn at any time and all marketing communications will include an unsubscribe link. Please view our privacy notice to understand how we use and protect the information that you provide to us.

© 2022 - EI Ltd, The University of Edinburgh